EAN News Network - Episode 5
Dr Gabrielle Macaron reviews data with ozanimod in treatment naïve vs experienced patients with relapsing multiple sclerosis presented at EAN 2022.
Germinal Center Activity Shows Potential As Target of Rituximab in NMOSD
Incorporating Technology and Virtual Reality in Parkinson Disease and Neurological Disorders: Jay Alberts, PhD
Potential Therapeutic Role of the Endocannabinoid System for Migraine
Differences in the Genetic Mutations of ALS: Anna Underhill, BS